Compounding Pharmacies
Compounding Pharmacy Compliance: What to Verify Before You Prescribe

Every compounding pharmacy describes itself as high quality. The useful question is not what they claim but what you can independently confirm — and most of it is confirmable in under twenty minutes using public databases.
This is the verification workflow. For what the underlying standards actually mean, see our quality and compliance reference; this page is about checking a specific pharmacy.
Step 1 — Confirm Licensure Yourself
The Pharmacy's Home-State License
Every state board of pharmacy publishes a license lookup. Search the pharmacy's name, confirm the license is active and unrestricted, and note any disciplinary history — boards typically publish actions against a license alongside it.
Non-Resident Licensure for Your Patients' States
This is the one practices miss. A pharmacy must hold a non-resident pharmacy license in every state it ships into. A pharmacy licensed in Florida cannot lawfully ship to your patient in Ohio without Ohio non-resident licensure.
Check your own state's board lookup for the pharmacy's name, not just the pharmacy's home state. If you practice across state lines or use telehealth, check each one.
Step 2 — Search the FDA's Public Records
Three searches, all free:
- Warning letters. The FDA publishes these in a searchable database. Search the pharmacy name. A warning letter to a compounder typically concerns sterility failures, insanitary conditions, or inadequate testing — all directly relevant to what you are about to prescribe.
- Form 483 observations. Issued at the close of an inspection, these list what the investigator observed. They are less severe than a warning letter but informative.
- Recalls. Compounded product recalls are published and are the clearest signal of a quality failure that reached patients.
A clean record is not proof of quality — many pharmacies are simply not inspected often. A poor record is close to disqualifying.
Step 3 — Request a Certificate of Analysis
Ask for a COA on a lot of something you would actually prescribe. What it should contain:
| Field | What to look for |
|---|---|
| Product and lot number | Must match a real dispensed lot, not a generic sample |
| Identity | Confirms the compound is what the label says |
| Potency / assay | Usually expressed as % of label claim, with an acceptance range |
| Purity / impurities | Related substances quantified |
| Sterility | Required for any injectable |
| Bacterial endotoxin | Separate from sterility, and required for injectables |
| Testing laboratory | Named third party, not "internal QC" |
| Test date | Should correspond to the lot, not be years old |
Licensed Healthcare Practitioners
6,500+ physician-grade product SKUs, bulk-tier pricing, and direct shipping to your practice. NPI verified, no consumer access.
The two things that matter most: whether an independent laboratory is named, and whether endotoxin testing appears for injectables. Sterility alone is not sufficient — endotoxins are pyrogenic and survive sterilisation.
Step 4 — Ask the Questions With Wrong Answers
The value here is less in the right answer than in how the question is handled.
| Question | A good answer | A concerning answer |
|---|---|---|
| "Are you USP 797 compliant?" | Yes, with specifics on clean-room classification and monitoring cadence | Vague reassurance, or conflating 795 with 797 |
| "Which lab does your third-party testing?" | Names the laboratory | "We test in-house" |
| "Will you send a COA for this lot?" | Yes, promptly | Reluctance, or a generic document |
| "On what basis are you compounding this?" | Cites patient-specific difference, shortage status, or bulks-list position | Avoids the question |
| "Do you hold PCAB accreditation?" | Yes with renewal date, or a straightforward no | Implies accreditation without holding it |
| "What is your beyond-use dating based on?" | Stability data or USP default, explained | An implausibly long date with no basis |
That last one is worth dwelling on. An unusually long beyond-use date is a quiet red flag — compounded preparations lack the stability testing behind commercial products, and a pharmacy assigning generous dating without data is making an assumption your patient absorbs.
Step 5 — Watch for the Structural Red Flags
- No prescription required. A supplier that will ship without one is not operating as a pharmacy.
- "Research use only" or "not for human consumption" labelling. That language is what permits the sale outside the drug framework. It is not a formality.
- Pricing far below the market. Testing, clean rooms, and cold chain cost money. A large discount usually means one of them was skipped.
- No pharmacist access. You should be able to speak to a pharmacist about a preparation.
- Marketing compounds with no lawful pathway. A pharmacy advertising a compound that is neither on the bulks list, nor a component of an approved drug, nor covered by a USP monograph is telling you how it operates.
The Twenty-Minute Version
If you only do four things: look up the license in your patient's state, search the FDA warning letter database, request a COA and check it names an outside laboratory, and ask what their beyond-use dating is based on.
Those four catch most of what matters.
Frequently Asked Questions
How do I verify a compounding pharmacy's license?
Use your state board of pharmacy's public license lookup — and check your patient's state, not just the pharmacy's home state. Shipping across state lines requires non-resident licensure in the destination state.
Where can I check FDA warning letters?
The FDA publishes warning letters, Form 483 inspection observations, and recalls in free public databases, all searchable by company name.
What should a certificate of analysis include?
Product and lot number, identity, potency against label claim, purity, and for injectables both sterility and bacterial endotoxin results — with the testing laboratory named and a test date matching the lot.
Is in-house testing acceptable?
Internal quality control is normal, but independent third-party verification is the stronger signal. A pharmacy that only tests internally is grading its own work.
What does an unusually long beyond-use date indicate?
Compounded preparations lack the stability testing behind commercial products, so dating should be based on stability data or USP defaults. Generous dating without a stated basis is a quiet red flag.
What is the single fastest check?
Look up the pharmacy's license in your patient's state. It takes a minute, it is a hard legal requirement, and gaps are more common than practices expect.
More from the blog
Continue reading

Low Testosterone Symptoms: When to See a Doctor
The symptoms of low testosterone, which ones are specific and which are not, what else causes them, and when the pattern warrants clinical evaluation.
Sep 7, 2026

Women's Hormone Panel: What to Test Before Starting Therapy
Which hormone and metabolic labs providers order before therapy, why cycle timing changes the result, and what the numbers cannot tell you.
Sep 4, 2026

PCOS and Hormonal Balance: How Peptide and Hormone Therapy Can Help
How PCOS is diagnosed, why insulin resistance drives it, and where metformin, inositol, GLP-1s, and compounded hormone options fit in a treatment plan.
Sep 2, 2026
For Licensed Providers
